Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-dose Rabeprazole in NERD
NCT01391715Phase 3Withdrawn
- Sponsor
- Inje University
- Start
- Aug 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of rabeprazole in non-erosive reflux disease (NERD) (2 arms), sponsored by Inje University. Primary endpoint: Symptom improvement at 2 week after double dose rabeprazole treatment. Planned start Aug 2011; status: withdrawn.
02
Drugs
rabeprazole
03
Conditions
non-erosive reflux disease (NERD)
Beyond the preview
Go deeper on NCT01391715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01391715.